Medfinder
Back to blog

Updated: January 1, 2026

Why Is Kevzara So Hard to Find? [Explained for 2026]

Author

Peter Daggett

Peter Daggett

Empty pharmacy shelf with scattered medication bottles, illustrating Kevzara availability challenges

Kevzara (sarilumab) is a specialty biologic only available at specialty pharmacies. Learn why it's hard to find and what steps to take to get it filled in 2026.

If you've been prescribed Kevzara (sarilumab) for rheumatoid arthritis, polymyalgia rheumatica, or polyarticular juvenile idiopathic arthritis, you may have quickly discovered that filling it isn't like picking up a regular prescription. Kevzara isn't sitting on the shelf at your corner drugstore—and that can feel alarming, especially when you're dealing with a painful inflammatory condition. Here's exactly why Kevzara is difficult to find, and what you can do about it in 2026.

What Is Kevzara and Why Does Finding It Feel So Complicated?

Kevzara is a biologic medication—a large, complex molecule manufactured using living cells. It belongs to a class called interleukin-6 (IL-6) receptor antagonists, which work by blocking IL-6, an inflammatory protein that drives conditions like RA and PMR. Unlike a small-molecule pill such as methotrexate or prednisone, biologic drugs like Kevzara require specialized handling, refrigerated storage, and careful distribution channels.

This means Kevzara is classified as a specialty medication. It can only be dispensed through specialty pharmacies—not standard retail chains like CVS, Walgreens, or Rite Aid. This single fact explains the majority of the confusion patients face when they first try to fill their prescription.

Is Kevzara in an FDA Drug Shortage in 2026?

As of 2026, Kevzara is not listed on the FDA's official drug shortage database. There is no nationwide supply crisis for sarilumab the way there was for tocilizumab (Actemra) during the COVID-19 pandemic, when that similar IL-6 blocker was in high demand for hospitalized patients. Kevzara is manufactured by Sanofi and Regeneron and is generally available through the specialty pharmacy distribution network.

That said, "not in shortage" doesn't mean "easy to get." Patients frequently report delays of days or even weeks between getting a prescription and receiving their first injection. The obstacles are usually administrative and logistical rather than a true supply problem.

Why You Can't Pick Up Kevzara at a Regular Pharmacy

Kevzara must be kept refrigerated at 36–46°F and requires careful cold-chain shipping. Standard retail pharmacies are not equipped to handle the volume, storage, or complex insurance billing requirements that come with specialty biologics. As a result, Sanofi distributes Kevzara exclusively through specialty pharmacies—either through a designated hub pharmacy like TheraCom or through specialty arms of larger chains (like CVS Specialty, Accredo/Express Scripts, Walgreens Specialty, or Optum Rx Specialty).

Your insurance plan may require you to use a specific in-network specialty pharmacy. If you try to use an out-of-network specialty pharmacy, your copay could be dramatically higher—or the claim may be denied entirely.

The Prior Authorization Barrier

Before most insurance plans will cover Kevzara, they require prior authorization (PA)—a formal approval process where your doctor must submit documentation proving that Kevzara is medically necessary. For Kevzara, this typically includes:

Documentation that you have a confirmed diagnosis of RA, PMR, or pJIA

Proof that you tried and failed (or couldn't tolerate) at least one conventional DMARD such as methotrexate

Sometimes, proof that you failed a less expensive biologic first ("step therapy")

Current lab values (neutrophil count, liver enzymes) meeting safety thresholds

The PA review process typically takes 1–14 business days. If your insurance denies the PA, your rheumatologist can appeal—but that can add weeks to the process. Meanwhile, you may be in pain waiting for your medication.

No Generic or Biosimilar: Why Kevzara Has No Cheaper Substitute

As of 2026, there is no FDA-approved generic or biosimilar version of Kevzara (sarilumab) in the United States. Unlike tocilizumab, which now has multiple biosimilars (Tofidence, Tyenne, Vegzelma), sarilumab remains brand-only. This means the list price stays high—around $4,774–$5,555 per 2-syringe carton (a 28-day supply). Without insurance or a savings program, Kevzara is out of reach for most patients.

The KevzaraConnect program from Sanofi offers a copay card for commercially insured patients (up to $15,000/year) and a patient assistance program for those who are uninsured or underinsured. See our post on how to save money on Kevzara in 2026 for details on these programs.

The Specialty Pharmacy Coordination Process

Even after prior authorization is approved, there's still coordination required. Here's what the typical process looks like once your rheumatologist sends the prescription:

Your doctor sends the prescription to a specialty pharmacy (often chosen by your insurer)

The specialty pharmacy contacts you to verify your information, insurance, and delivery address

Insurance benefits investigation is completed (can take 2–5 business days)

If PA is required and not yet approved, the pharmacy holds the order until PA comes through

Medication is shipped cold directly to your home or a local infusion center

If your specialty pharmacy has the medication in their own inventory, you can typically receive it within 2–5 business days of PA approval. But delays in PA—or being directed to an out-of-network specialty pharmacy—can push that out significantly.

How medfinder Can Help You Find Kevzara

If you're having trouble confirming where your Kevzara prescription can be filled, medfinder can help. medfinder is a service that calls specialty pharmacies and pharmacies near you to find out which ones can fill your Kevzara prescription. You tell us your medication, dosage, and location—and we do the calling. Results are texted directly to you, so you don't have to spend hours on hold.

Tips to Speed Up Getting Your Kevzara Prescription Filled

Ask your rheumatologist's office to initiate PA before you leave the appointment. Many offices have PA coordinators who can start the process immediately.

Enroll in KevzaraConnect. Sanofi's support program (1-844-538-9272) can help navigate insurance and provide a free 30-day supply while your PA is pending.

Confirm your insurance's preferred specialty pharmacy before your doctor sends the prescription—using an out-of-network pharmacy is a common cause of delays and unexpected costs.

Have your lab work done before the prescription is sent. A current CBC and liver function panel are often required before Kevzara can be dispensed.

Follow up proactively. Call the specialty pharmacy 2 business days after the prescription is sent to confirm they received it and that PA documentation is complete.

The Bottom Line

Kevzara is hard to find not because it's in short supply, but because it's a specialty biologic with a complex distribution and insurance process. Once you understand the hurdles—specialty-only distribution, prior authorization, and no biosimilar options—you can take targeted steps to navigate them. For more actionable strategies, read our guide on how to find Kevzara in stock near you.

Frequently Asked Questions

No. As of 2026, Kevzara (sarilumab) is not listed on the FDA's official drug shortage database. Kevzara is generally available through specialty pharmacies. The main barriers to access are insurance prior authorization and specialty-only distribution, not a supply shortage.

Kevzara is a specialty biologic that requires refrigerated storage and specialized distribution. It is only dispensed through specialty pharmacies—not standard retail pharmacies. Your insurance plan will typically direct you to a specific in-network specialty pharmacy such as CVS Specialty, Accredo, or Walgreens Specialty.

Most commercial insurance plans cover Kevzara, but it typically requires prior authorization. Plans often require documentation that you have tried and failed at least one conventional DMARD like methotrexate before approving Kevzara. Some plans also require step therapy, meaning you must try a less expensive biologic first.

Prior authorization for Kevzara typically takes 1 to 14 business days, depending on your insurance plan and how quickly your rheumatologist's office submits documentation. If denied, an appeal can add additional weeks. To minimize delays, ask your rheumatologist to initiate PA at your appointment.

No. As of 2026, there is no FDA-approved generic or biosimilar for Kevzara (sarilumab) in the United States. Kevzara is only available as a brand-name biologic from Sanofi and Regeneron. The KevzaraConnect program offers savings for eligible patients—commercially insured patients may pay as little as $0/month with copay assistance.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Kevzara also looked for:

30,351 have already found their meds with Medfinder.

Start your search today.

30K+
5-star ratingTrusted by 30,351 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?